DeepMed Research

National Eye Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1968-01-01

Employees: 101

Market Cap: -

Website: http://www.nei.nih.gov

Clinical Trials

Natural History and Genetic Studies of Usher Syndrome

Completed

Conditions: Congenital Deafness
Usher Syndrome
Retinitis Pigmentosa
Retinitis Pigmentosa and Deafness
Retinitis Pigmentosa Syndromic

First Posted Date: 2005-03-30

Last Posted Date: 2019-12-12

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 249

Registration Number: NCT00106743

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Queens College of the City University of New York, New York, New York, United States

Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage

Phase 3

Completed

Conditions: Retinal Vein Occlusion
Macular Edema, Cystoid
Macular Edema

First Posted Date: 2005-03-21

Last Posted Date: 2008-03-04

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 1260

Registration Number: NCT00106132

Locations: 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States

Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation

Phase 3

Completed

Conditions: Diabetic Retinopathy
Diabetic Macular Edema
DME

First Posted Date: 2005-03-14

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 5

Registration Number: NCT00105404

Locations: 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States

Cyclosporine Implant for Ocular Graft-Versus-Host Disease

Phase 1

Completed

Conditions: Graft Vs Host Disease

First Posted Date: 2005-01-31

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 4

Registration Number: NCT00102583

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders

Phase 1

Completed

Conditions: Macular Degeneration
Retinal Vein Occlusion
Diabetic Retinopathy

First Posted Date: 2005-01-13

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 120

Registration Number: NCT00101764

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration

Phase 3

Completed

Conditions: Macular Degeneration

First Posted Date: 2004-12-22

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 30

Registration Number: NCT00100009

Locations: 🇺🇸
Doheny Eye Institute, Los Angeles, California, United States
🇺🇸
Wills Eye Hospital, Philadelphia, Pennsylvania, United States
🇺🇸
Southeastern Retina Associates (SRAKT), Knoxville, Tennessee, United States

and more 19 locations

Visual Cortex Stimulation in Patients With Amblyopia

Phase 1

Completed

Conditions: Amblyopia
Anisometropic Ambyopia
Amblyopia, Suppression

First Posted Date: 2004-11-18

Last Posted Date: 2006-06-26

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 10

Registration Number: NCT00097162

Locations: 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States

Efficacy of Elevated CD4 Counts on CMV Retinitis

Completed

Conditions: Acquired Immunodeficiency Syndrome
Cytomegalovirus Retinitis

First Posted Date: 2004-09-20

Last Posted Date: 2008-03-04

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 15

Registration Number: NCT00091884

Locations: 🇺🇸
National Eye Institute (NEI), Bethesda, Maryland, United States

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Phase 1

Completed

Conditions: Von Hippel-Lindau Syndrome

First Posted Date: 2004-08-13

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 5

Registration Number: NCT00089765

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Immune Indicators of Uveitis

Completed

Conditions: Suppressor of Cytokine Secretion
GITR
GITR Ligand
Uveitis
Immunosuppression

First Posted Date: 2004-08-12

Last Posted Date: 2017-07-02

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 100

Registration Number: NCT00089739

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy